Earnings Call · Q2 FY2021·2021-08-12

Q2 21EPS -100.00%*·Rev n/aQ1 21EPS -100.00%*·Rev n/aQ4 20EPS -67.19%·Rev n/aQ3 20EPS +20.00%·Rev n/a⚠ consensus missing

ZEVRA THERAPEUTICS, INC. ZVRA

Jason Rando — Representative

Travis Mickle — Chief Executive Officer

LaDuane Clifton — Chief Financial Officer

−10.7%1d on move date−10.9% vs SPY3d−8.5%5d−12.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ZVRA calls or request research access.

More ZVRA calls Browse calls Request research access